Clofarabine combinations as acute myeloid leukemia salvage therapy.
about
Treatment of Acute Myeloid Leukemia in Adolescent and Young Adult PatientsAllogeneic hematopoietic cell transplantation in patients with AML not achieving remission: potentially curative therapy.Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia.Clofarabine in leukemia.Prognostic implications of chromosome 17 abnormalities in the context of monosomal karyotype in patients with acute myeloid leukemia and complex cytogeneticsThe role of clofarabine in acute myeloid leukemia.Clofarabine: emerging role in leukemias.Clofarabine for the treatment of adult acute myeloid leukemia.The histone deacetylase inhibitor SAHA sensitizes acute myeloid leukemia cells to a combination of nucleoside analogs and the DNA-alkylating agent busulfan.Interstrand crosslink inducing agents in pretransplant conditioning therapy for hematologic malignancies.Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia.Report of a phase II study of clofarabine and cytarabine in de novo and relapsed and refractory AML patients and in selected elderly patients at high risk for anthracycline toxicity.Phase 1 dose-escalation trial of clofarabine followed by escalating dose of fractionated cyclophosphamide in adults with relapsed or refractory acute leukaemiasSalvage therapy for relapsed or refractory acute myeloid leukemiaClofarabine in the treatment of acute myeloid leukemia in older adultsClofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.Clofarabine in pediatric acute leukemia: current findings and issues.Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup.Emerging strategies for the treatment of older patients with acute myeloid leukemia.Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation.Update on optimal management of acute myeloid leukemiaClofarabine desensitization: A case report: Leukemia research reports.Use of clofarabine for acute childhood leukemia.Feasibility of clofarabine cytoreduction before allogeneic transplant conditioning for refractory AML.Last exit clofarabine?Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-M
P2860
Q26799609-819EA339-CE04-49A9-82CA-F9A036CA52A7Q30399209-CD1601A5-C778-4BFE-8588-70FC85397683Q33949752-2A253528-D2A5-467F-9BA7-7DBA1516E0DFQ34150263-7630E489-B1D4-4F4A-8877-165D1FE3E61DQ34205736-9C8FEEB7-5D33-49E3-B2EA-45A6798DAD28Q34298181-BC94F333-25EE-45F5-A620-37DF10643A0CQ35000135-38671B4A-23EA-4675-B148-707DC89559D3Q35009273-FBEC064D-AD37-42FA-9666-6E89C71676D9Q35060679-05DF7533-9773-492E-AA73-64964A1A2B83Q35136616-A34C0156-40F9-4249-AA26-F2B89EBBEAF5Q35278018-AE726CBC-DF9C-46A1-AE27-FC4AFB0CA8D0Q35584427-4DD69FC9-001C-4BD1-824C-074477B13670Q36075766-C84F643D-019A-4037-9A75-8EEBAB903C4BQ36612564-A152F70E-D10C-45D4-B567-DC595524BD83Q36776439-F5BA2382-E055-4F58-99E7-9140E638E318Q37140698-DBD75801-5105-4352-9AA6-CDE1E02B8C9EQ37987061-39966411-A0A8-493C-BDD9-0F0F6E51681BQ38226402-D0EAA6C2-8600-493B-8113-A98EA34E3C8AQ38818726-09E14A20-B7C6-4F10-B60C-F513AA87F374Q39632454-8C910039-369A-4494-B9A3-D683500B2342Q40815983-0B99D484-E24B-410F-B436-C6AF52B1EE2BQ41894404-D68E0362-F0B0-4CAB-A74D-920043680FF2Q42268932-8F18006D-F04C-451C-8A80-A423B6617BC5Q42737704-320D7932-CE6F-49F2-95ED-9BDA4B990BEEQ43140221-92F4F383-FF93-48F9-B0BE-BC3545515FBDQ43225846-952E24E8-3AC9-44F5-B1AB-AC25A1C56CF5Q51098678-C37DEDD3-91BC-4950-B5CA-F468098CCC26
P2860
Clofarabine combinations as acute myeloid leukemia salvage therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Clofarabine combinations as acute myeloid leukemia salvage therapy.
@en
Clofarabine combinations as acute myeloid leukemia salvage therapy.
@nl
type
label
Clofarabine combinations as acute myeloid leukemia salvage therapy.
@en
Clofarabine combinations as acute myeloid leukemia salvage therapy.
@nl
prefLabel
Clofarabine combinations as acute myeloid leukemia salvage therapy.
@en
Clofarabine combinations as acute myeloid leukemia salvage therapy.
@nl
P2860
P50
P356
P1433
P1476
Clofarabine combinations as acute myeloid leukemia salvage therapy.
@en
P2093
Monica Kwari
Xuelin Huang
P2860
P304
P356
10.1002/CNCR.23816
P407
P50
P577
2008-10-01T00:00:00Z